mda quest magazine published interesting article reported amy madsen recent research member kennedy disease association scientific review board dr la spada instrumental kennedy disease research many years research opportunity still needs study testing preliminary findings reflect could potential treatment quest article arimoclomol slows disease progression sbma mice mice treated small molecule compound improved muscle strength increased motor neuron survival boosted production motor neuron support molecule called vegf mda research grantee albert la spada colleagues found treatment compound called arimoclomol help improve muscle function mice disease resembling sbma article highlights mda supported research team shown treatment small molecule compound called arimoclomol improved nerve cell survival resulting increased muscle strength function mice disease resembling spinal bulbar muscular atrophy sbma arimoclomol thought work inducing heat shock response helps cells combat exposure heat types stress although still early stage findings ultimately could lead development arimoclomol similar compounds treatment sbma amy madsen march mice disorder mimicking human spinal bulbar muscular atrophy sbma kennedy disease treated experimental therapy called arimoclomol showed improved nerve cell survival increased body weight better muscle strength function mice receive treatment small molecule compound arimoclomol thought work inducing heat shock response levels naturally occurring heat shock proteins hsps increase cells exposed heat types stress findings could lead development arimoclomol similar compounds treatment sbma reported online feb brain mda supported albert la spada university california san diego la jolla contribution work read full report available fee see co induction heat shock response ameliorates disease progression mouse model human spinal bulbar muscular atrophy implications therapy treatment began symptom onset mice study randomly assigned two different groups treated milligrams per kilogram body weight per day arimoclomol dissolved drinking water treatment group water alone control group treatment began months age symptom onset lasted six months late stage disease results show treatment arimoclomol time symptom onset dramatically delayed disease progression investigators examined month old sbma mice found treated arimoclomol demonstrated significantly improved hind limb muscle force percent stronger muscles untreated mice showed percent improvement motor unit nerve cell muscle fibers activates significantly increased muscle weight percent increase untreated mice number motor neurons survived mice treated arimoclomol also higher levels protein called vascular endothelial growth factor vegf protein may protect nourish nerve cells treatment arimoclomol effect muscle force mice sbma like disorder investigators noted suggests beneficial effects arimoclomol mice likely due specific effects drug disease processes opposed indiscriminate improvement muscle force arimoclomol activated heat shock response several treatment strategies sbma focused inducing overexpression heat shock proteins hsp hsp hsps function chaperones proteins helping fold right shape preventing forming abnormal clumps blocking cell death data current study showed levels heat shock protein hsp times higher spinal cord three times higher hind limb muscles mice treated arimoclomol mice receive treatment upregulation increase heat shock response treatment arimoclomol may therapeutic potential treatment sbma researchers say